Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • World View
  • Published:

Academic clinician–scientists risk becoming an endangered species

Subjects

Barriers to their training and retention threaten medical research

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gill, G. N. Am. Scholar 53, 353–368 (1984).

    Google Scholar 

  2. Kwan, J. M. & Gross, C. P. JAMA Netw. Open 6, e2332982 (2023).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen O’Rahilly.

Ethics declarations

Competing interests

In the past 2 years, S.O.R. has provided consultancy services to Pfizer, AstraZeneca, Northsea Therapeutics, Third Rock Ventures and Medicxi and received research support from GSK.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Rahilly, S. Academic clinician–scientists risk becoming an endangered species. Nat Med 29, 2989 (2023). https://doi.org/10.1038/s41591-023-02626-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02626-8

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing